How We Research & Evaluate Microneedling Products

Home / Reference Library

The short answer

We evaluate products by intended use, documented specifications, evidence quality and transparent limitations. A compelling ingredient story or a manufacturer testimonial is not enough to establish clinical benefit or procedural compatibility.

By Microneedling Resource · Updated September 27, 2026 · AI-assisted research and writing. This educational page has not been medically reviewed.

On this page · Evidence hierarchy · Eligibility before ranking · Core fields · How changes are handled · Independence and corrections · Follow a claim from source to conclusion · Keep researching · Sources & evidence notes

StageRequired workOutput
DefineIdentify the question and intended useOne clear comparison scope
VerifyCheck product identity and current manufacturer informationSource-linked facts and unknowns
Evaluate evidenceSeparate regulatory, clinical and commercial claimsClaim-by-claim confidence notes
CompareApply the same fields across eligible productsReadable table with limitations
ReviewCheck conflicts, wording, sources and updatesMeaningful revision record

Evidence hierarchy

Regulatory information establishes labeling and safety context. Systematic reviews and peer-reviewed studies inform clinical claims. Professional medical organizations provide patient education. Manufacturer documentation supplies product identity, formulation and directions, but is not independent proof of clinical superiority.

Eligibility before ranking

A product must fit the intended audience and use before convenience, price or ingredient features are compared. Missing critical documentation prevents a recommendation. We do not assign points to unknown facts or manufacture a winner to complete a list.

Core fields

SerumsDevices
Full current INCI; intended topical useExact model; intended user and indication
Package format, volume and handlingCartridge system and compatible replacements
Fragrance, colorants and disclosed pHSettings, power format and instructions
Disclosed testing and traceabilityRegulatory documentation and support
Price with date and region when checkedPurchase and ongoing consumable costs
Strengths, limitations and missing dataStrengths, limitations and missing data

Testing disclosure

The initial comparison library is based on document research. No hands-on product tests, laboratory assays, clinical trials or clinician reviews have been performed by this site or claimed in this build.

How changes are handled

Prices and availability are volatile and should be checked close to a buying decision. Formula or labeling changes trigger a new comparison review. Medical references should be revisited when new evidence or regulatory communications appear. A displayed update date changes only after meaningful review or revision.

Independence and corrections

Commercial relationships must be disclosed at the point of recommendation. Editorial conclusions should not be sold. Corrections should identify the affected claim, supporting evidence and change made. See the editorial, sourcing and disclosure policies for the operational standards.

Follow a claim from source to conclusion

Our evaluation record separates what a source reports from our interpretation. This makes it possible to update a conclusion when the product changes or new evidence appears. Missing fields stay visible.

Record or decisionWhat to write down
QuestionOne clearly defined outcome or buying decision.
SourceOriginal report, regulatory record or manufacturer document.
ExtractionPopulation, product, comparator, time point and finding.
LimitBias, uncertainty, missing data and scope.
ConclusionA statement no broader than the supporting evidence.
What would justify changing a conclusion?

A new relevant study, corrected source, changed formulation or updated regulatory record may change the answer. A new marketing slogan alone does not. Meaningful updates should identify what was reviewed rather than merely refreshing a date.

Keep researching

Sources & evidence notes

Sources checked September 27, 2026. Linked regulatory and research sources describe their own populations and procedures; they do not establish that every commercial device or serum is equivalent.